Effects of metformin+sitagliptin versus metformin + glibenclamide combinations on lipid profile, body mass index and kidney function in Iraqi patients with type 2 diabetes mellitus.
Until 1995, only two options for pharmacologic treatment were available for patients with diabetes; sulfonylurea (for type 2 DM only) and insulin (for type 1 or 2). Since 1995, a number of new oral agents, injectables, and insulins have been introduced in therapy. Currently, six classes of oral age...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy / Mustansiriyah University
2013-06-01
|
Series: | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/190 |